Evidence map›Paper›PMID 40874405›Full record

ArticleExpert opinion on drug delivery2025

Drug depots for obesity targeting metabolism, appetite, and inflammation.

Muhammad Fayyaz, Andrew M Smith

Abstract readEditorial
In one paragraph

Article in Expert opinion on drug delivery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Muhammad FayyazDepartment of Bioengineering, University of Illinois Urbana-Champaign, Urbana, IL, USA.
Andrew M SmithDepartment of Bioengineering, University of Illinois Urbana-Champaign, Urbana, IL, USA.

Funding

The Center for Label-free Imagingand Multiscale Biophotonics (CLIMB)P41EB031772 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Stephen A Boppart · 2022 to 2026
$7.6M
The epigenetic regulation of inflammation in tissue repair and vascular diseaseR35HL167143 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Katherine Ann Gallagher · 2023 to 2026
$4.2M
Nanomedicine-Based Targeting of Inflammatory Macrophages in Diabetic Wound RepairR01DK131782 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Katherine Ann Gallagher, Andrew Michael Smith · 2022 to 2026
$2.4M
Hyperplexed Quantum Dots for Multidimensional Cell Classification in Intact TissueR01EB032249 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI SMITH, ANDREW MICHAEL · 2021 to 2024
$2.3M
Macrophage-Targeted Drug Delivery Depot for Obesity and Comorbid Type 2 DiabetesR01DK139924 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Andrew Michael Smith · 2024 to 2026
$1.8M
NHLBI NIH HHS R35 HL167143NIBIB NIH HHS P41 EB031772NIBIB NIH HHS R01 EB032249NIDDK NIH HHS R01 DK131782NIDDK NIH HHS R01 DK139924
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adiposebrowningControlled releasediabetesdrug deliverydyslipidemiaGLP-1nanomedicine

Identifiers

PMID40874405
PMCPMC12781128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.